K Line on the Rebound

first_imgzoom The Japanese shipping conglomerate K Line posted Yen 26.8 billion (USD 223.1 million) in net income for the fiscal year ending March 2015, a 61% surge year-on-year.The company’s revenues stood at JPY 1.35 trillion, against JPY 1.22 trillion, up 10% from the prior year.K Line’s container shipping business rebounded from a loss of JPY 100 million, posting JPY 20.6 billion profit in 2014 fiscal year.The company said its container cargoes rose 4% year-on-year amid steady cargo movements and falling bunker prices pushing company into the black.The company’s dry bulk business recorded higher revenues but lower income amid market fluctuations. A similar situation has been reported in the company’s car carrier sector.Other businesses of the conglomerate remained steady except for its offshore energy arm that recorded a loss.For the 2015, the company expects operating revenues to reach JPY 1.46 trillion and a net income of JPY 20 billion.World Maritime News Stafflast_img read more

Moroccos Health Ministry to Reduce Price of Cancer Medicines

Rabat – Minister of Health Anas Doukkali has released a list of the 210 drugs to be reduced in price. The official list of new prices has been posted online, starting on page 61 of an 86-page document. The newly released list includes medicines for chronic illnesses such as cancer and mental illness.The list shows the prices for the public before and after the reduction, as well as the prices at the hospital before and after being reduced.The Ministry’s decision to reduce prices is an example of implementation of the national drug policy, specifically decree 2.13.852, issued on December 19, 2013. Since putting this policy into effect, the ministry has been reducing the cost of drugs in groups of two or three hundred.So far, over 3,000 pharmaceutical medicines are now more affordable for the public.The medicines chosen for reduction are those used to treat chronic illnesses including cancer and mental illnesses.Read also: Moroccan Scientist Develops New Cancer Treatment read more